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Abstract 
 
As compared to academic sites, opportunities for quality research opportunities 
are limited in a community hospital setting, decreasing the availability of investigational 
treatment options for the patient population served.  When considering the feasibility of 
research opportunities, community hospitals must include the ethno-demographics of 
the surrounding community to ensure sustainable, inclusive programs without 
compromising research quality and ethics.  
Community hospital systems encounter many challenges in building effective 
research programs, such as (1) means to engage non-academic physicians to provide 
time for research; (2) dedicated research personnel (e.g. biostatistician, grant writer, 
etc) to identify and secure grant funding for investigator-initiated research projects; (3) 
on-site training programs for supporting clinical staff; (4) methods to meet enrollment 
targets; (5) unique and challenging local patient populations; and (6) initiating and 
facilitating positive collaborations with partnering research sites.     
There are limited peer-reviewed resources which specifically address the 
challenges of building research programs in community hospitals, which is an indicator 
of the complexity of achieving the goal. Additional targeted infrastructure research is 
required to align the efforts of all stakeholders and build capacity for sustainable 
programs.  These programs must integrate healthcare reform goals while also updating 
and maintaining research integrity and quality.   
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Background 
Assuring diversity in clinical trial participation is a national priority.  In 1993, the 
most recent amendment to the National Institutes of Health (NIH) Revitalization Act 
mandated the inclusion of women and minorities in clinical research and government 
sponsored human subject research including clinical trials.  This Act states that women 
and minorities must be included in all clinical research studies and must be included in 
Phase III clinical trials.  Trials must also be designed to permit valid subgroup analyses.  
The Act states that cost is not an allowable reason for excluding minorities and that the 
NIH will support outreach efforts to fulfill this mandate. (Baquet et al, 2006) 
The efforts of the NIH to support inclusion in research trials does not extend to 
primary industrial sponsors, whose principal motivation is to rapidly complete trial 
phases to move new pharmaceuticals and devices to market.  Often research protocols 
written by industry sponsors are not inclusive in nature and do not track minority 
inclusion statistics for research outcomes.  However, trials which are industry sponsored 
increase the financial viability of a research program and provide an increased level of 
sustainability  for the research portfolio. 
In a large investigation of the willingness of ethnic and racial minorities to 
participate in health research, it was concluded that the investigators “found very small 
differences in the willingness of minorities, most of whom were African-Americans and 
Hispanics in the US, to participate in health research compared to non-Hispanic whites. 
These findings, based on the research enrollment decisions of over 70,000 individuals, 
the vast majority from the US, suggest that racial and ethnic minorities in the US are as 
willing as non-Hispanic whites to participate in health research. Hence, efforts to 
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increase minority participation in health research should focus on ensuring access to 
health research for all groups, rather than changing minority attitudes.”  (Wendler, et al, 
2005) 
 If minority inclusion in research is not a matter of willingness, presumptive 
reasoning leads to a conclusion that lack of opportunities, information, education, 
cultural appropriateness, including building familiarity and trust, are the primary barriers 
to participation. 
It is hypothesized that community hospitals would be more successful in building 
research programs if their infrastructure is designed relative to number of available 
patient beds, medical staff specialties, ethno-demographics and primary patient 
services. 
 
Methods 
As the combined focus of the required Public Health practicum and Master‟s 
research, my studies include existing hospital systems, participant inclusion and 
accessibility, and ethics and compliance issues associated with a strategic re-design of 
research infrastructure for a community healthcare system.   
Exemption was obtained from the UNC-CH IRB (Appendix A), and telephone 
calls were made to the administration of 60 Small, Medium and Large hospitals listed on 
the Reuters Top 100 Community Hospitals for 2009 (Appendix B).  The intent was to 
obtain an electronic mail address to deliver a de-identified survey instrument (Appendix 
C) to each site for completion.  The survey contained basic hospital information such as 
bed size, primary specialties, affiliation with academic sites and functioning research 
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trials programs.  Existing programs, if identified, were to be further  broken down into 
the number of trials, active research disciplines (e.g., resident, behavioral, medical, 
bench), primary use of central or local IRB, funding sources, presence of centralized 
research oversight, research software systems, and grants and contracts oversight at 
the hospital location. An email was drafted to introduce the survey and identify the intent 
of the project (Appendix D). 
Obstacles were encountered in obtaining contact information.  Many sites 
required permission from their legal counsel prior to participating in the survey.  All of 
these sites ultimately did not respond.  Many sites requested and were supplied with the 
survey instrument, proof of IRB review and approval of the exemption request and also 
the content of the email request. Often sites did not respond further, while others 
relayed a general distrust of being portrayed unfavorably, despite assurances that no 
site would be identified by name.    Calls were refused or unreturned by approximately 
33 of the 60 hospitals contacted by telephone.  Of the 27 hospitals contacted via email, 
only 8 returned surveys.  Four of the surveys returned were blank on return and 
therefore could not be included in the results.  When the sites were re-contacted, they 
did not respond.  The remaining 4 surveys indicated no affiliation with academic 
research sites but 3 of the sites indicated they were part of a regional healthcare 
system.  One of the sites indicated participation in all primary specialties on the survey, 
but this site indicated no participation in research trials.  Figure 1 is a breakdown of the 
responses for the remaining 3 sites which completed the survey. 
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Figure 1 
Site IRB Research 
Type 
Volume Funding 
Primary 
Central Research 
Office 
Grants & 
Contracts 
CTMS 
1 Local R, M >20 Federal Yes Yes No 
2 Central R, M >20 Industrial No NA NA 
3 Local M, B 10-15 Industrial Yes No No 
R-Resident, M=Medical, B=Behavioral 
NA=No Answer 
 
 
Due to limited results gained from the planned survey and the seeming lack of 
supportive community hospital researchers, it is necessary to use available published 
literature as well as knowledge from personal experience gained through building the 
infrastructure in the community healthcare system in Dearborn, Michigan where I am 
employed to draw outcomes.  My experience in research to this point is supportive of 
the belief that the experiences encountered building the research program in Dearborn 
are not unique, but rather a realistic model of the challenges faced by other community 
hospitals seeking to engage in research without a formal affiliation with an academic 
partner. 
 
Foundation 
The strategic redesign of a research program in a community hospital setting 
presents a change in mindset to a traditional academic approach.  Translation of 
research systems and theories developed in academic systems over many years of 
experience may not integrate effectively into a system of community hospitals that have 
limited dollars (most programs are funded through the operating budget), limited in 
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systems resources, short on personnel, and lacking in research education and training. 
Changing organizational culture is an important catalyst to success.  
The depressed economic condition in Michigan has negatively impacted not only 
the residents of the state, but also many Michigan healthcare providers‟ ability to sustain 
and grow. Building a solid research infrastructure in the current economic climate forces 
the creativity to develop a more inclusive approach which will encourage patient 
participation and physician involvement in research. These efforts will help to build a 
trusting relationship with the largely Muslim and Spanish communities surrounding the 
hospital and provide much needed healthcare service options to the residents.  
 
Unique Aspects of Community Hospitals 
Research infrastructure in a community hospital is dependent upon choices, all 
contributing to a sustainable research base.  Many community hospitals choose to have 
a formal “affiliation” with a major university or academic research site.  This relationship 
offers access to existing infrastructure, including supporting policies of a larger and 
more established research site.  The distinct disadvantage for a community hospital is 
loss of individual brand identity.  The hospital becomes subordinate to the academic 
research site. 
Community hospitals may also choose to enter into sub-contracted agreements 
with collaborative groups, such as the Michigan Community Clinical Oncology Group 
(CCOP), the National Heart, Lung and Blood Institute (NHLBI), Southwest Oncology 
Group (SWOG) or the Pelvic Floor Disorders Network (PFDN), as some examples.  
These cooperatives are usually facilitated through a major university hospital site.  The 
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advantages are association with projects endorsed by the National Institutes of Health 
(NIH) along with the presumed prestige of such an association, and access to organized 
research processes facilitated through experienced research sites.  The disadvantages 
of the cooperative association as a subcontractor is inadequate cost recovery, 
consistently falling well below the actual cost for the hospital to perform the research on 
behalf of the cooperative group.  Most cooperative group budgets are non-negotiable 
and do not include appropriate reimbursement for personnel and indirect costs. For 
example, our participation in the Michigan CCOP produces a loss of approximately 
$200K each year.  Admittedly, our hospital has fallen below the CCOP standard for 
enrollments; however, the CCOP salary budget would still be well below the actual cost 
even if our site were a “high performer”.     
Although the draw to perform trials through cooperative research groups is 
attractive to physicians with current or past university associations, the cost to an 
unaffiliated community hospital to support research of this type is considerable over 
time. Without an adequate portfolio of research providing income to support staff and 
systems involved with cooperative group trials, it is ill-advised for a community hospital 
to dedicate its resources to this type of membership. 
If the desired outcome is autonomy for the research program, collaborations with 
site partners to build experience, credibility and client base are paramount as 
community hospitals do not typically have the infrastructure required to support grant 
funded research in the program development phase.  Standards for federally funded 
research, such as a Department of Health and Human Services (DHHS) negotiated 
indirect cost rate for the hospital must be secured.  Collaborations allow for access to 
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trials while developing the infrastructure and experience to independently support grant-
funded research trials in the future. 
 
Specific Issues 
Specific issues identified below are derived from dedicated operational activities 
experienced through the Master‟s practicum.  The practicum and all activities were 
performed in a community healthcare system located in Dearborn, Michigan.   
As compared to academic sites, community hospitals often encounter challenges 
in developing a thriving research program in the following systems: 
 
Business Structure:  A lack of a clinical research “hierarchy” and reporting structure 
within the hospital.  Research programs are often secondary to other strategic initiatives 
of the organization, such as: 
 service excellence initiatives which do not include research targets 
 quality initiatives which compete with active research projects 
 medical accreditations in research are not an organizational priority 
Operational goals and strategic plans must include the research program as an 
integral component of the organizational business identity. Targets must 
appropriately define growth by focusing on revenue, staff productivity and enrollment 
trends.  The organization must be willing to invest in the promotion and development 
of a viable and robust research program.  Without this investment, attempts to 
integrate the research program into the hospital culture will be ineffective. 
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Patient Registration: Systems are not designed to support the specific regulations 
with regard to research trials (e.g., de-identification of reports, images, and files).  
The Health Insurance Portability and Accountability Act (HIPAA) HI-TECH 
regulations may not be developed within the hospital to be inclusive of research 
registration processes and systems. 
 
Finance and Accounting:  Systems are not designed to accommodate cost recovery 
for research, forcing facilitation “by hand” and increasing the probability of billing 
errors and major research finance compliance violations, especially when research 
subjects are enrolled through central registration systems. Variability in research 
budgets creates a particularly complicated challenge to ensuring financial 
compliance, as antiquated billing systems do not have the capacity to accommodate 
research billing requirements.  Distribution of research payments to the appropriate 
cost centers is non-existent or inefficient.  There is often resistance from financial 
services within the hospital to “close out” accounts, which results in inappropriate 
claims being assigned to secondary insurance payers and/or to the research 
subjects themselves, resulting in double-billing which is not immediately identified.  
Financial compliance in research is consistently the highest contributor to research 
risk in the community hospital setting.   
 
Compliance: Financial as well as regulatory compliance, may also present 
challenges in large community healthcare systems unequipped to maintain oversight 
for research being performed at affiliate locations.  Hospital oversight for research 
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projects creates compliance and risk issues in contracting for activities, 
indemnification for the site, and budgeting trials for cost recovery. 
Community hospitals without centralized Clinical Research oversight and 
systems often lack  standard operating procedures specific to research activities.  
Small research endeavors can often be treated as an extracurricular secondary to 
the “main” objectives of the department, with “volunteer” research staff developing 
independent processes which may or may not be compliant with Federal 
Regulations for research.  These important omissions in structure and oversight are 
not often apparent until they are identified through monitoring or audit of the 
research site. This sub-standard program development is reflective of the lack of 
research education and training available at the unaffiliated community hospital. 
  
Communications: Centralized Clinical Trials operations are often located in the 
“main” hospital, with outreach to hospital affiliates and collaborating community 
practices performed through sporadic email and telephone communications only.  
Affiliated hospital sites may not be present for training and education opportunities if 
made available only at the main hospital site, leading to gaps in learning and 
potential compliance issues.   
 
Physician Investigators: Physicians in community hospitals are often in private 
practice. Even employed physicians who wish to participate in research often do not 
have dedicated time.  Those who do participate are required to “donate” time, and 
contracted hospital clinic hours or hours devoted to specialty practice interfere with 
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the ability to add research activities to the physicians‟ complicated schedule.  Those 
who do participate may not have time to appropriately oversee their projects and 
maintain standards of Good Clinical Practice (GCP), leading to potential compliance 
issues and protocol violations. 
Most community hospitals do not have “clinical trials” insurance policies, 
which exposes the hospital to risk if contracting on behalf of a physician in 
community practice, or even if contracting for research performed on site.  The 
hospitals are unaware that standard hospital insurance and malpractice insurance 
do not cover the hospital for research-related injuries that may occur on a research 
trial, as legal counsel untrained in research liability may not identify the risk when 
reviewing research contracts. Physicians with hospital privileges will often cite 
association with the hospital in order to participate in trials performed in their private 
practices for which the sponsor requires oversight by a larger entity than the practice 
itself. These contracts require the community hospital to accept risk on behalf of the 
community physician for the performance of the research activities.  Signing 
research contracts on behalf of independent physicians may be especially 
dangerous for a community hospital if appropriate indemnification clauses are not 
included and/or the hospital does not have the appropriate infrastructure to provide 
oversight of the physician‟s research activities. 
 
Staff and Budget: The limitations for use of hospital services and staff are not clear 
to those outside of hospital employ and the research reporting structure can be 
multi-layered and complex to navigate politically. Community practices become 
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confused about jurisdiction for oversight, hospital staff availability for research 
activities, budgeting for salary, use of hospital facilities and indirect costs.  Without 
appropriate research training, a hospital may inappropriately agree to allow research 
activities to be performed on site without ensuring that costs associated with the use 
of facilities, services and personnel are compensated. 
 
Compliance & Oversight:  Research oversight for community-based physicians with 
hospital privileges conducting research activities in their practices can be 
fragmented and inadequate.  The affiliated locations also provide challenges to 
research oversight. Dedicated personnel and resources to conduct objective 
compliance activities in private practices become secondary to compliance issues at 
the hospital site itself, while affiliate sites are often undermanaged.  However, 
community-based research in private practice which is supported and endorsed by 
the hospital through personnel, services and/or contracted agreement is subject to 
the same degree of compliance risk for the hospital. 
External practices participating in research may not have the means to report 
trial activities centrally to the hospital in real time, e.g., through the use of a Clinical 
Trials Management System (CTMS).  There may be no centralized system to track 
enrollments, research activities and flow of funds.  Due to the many sites involved in 
these practices, research funds are generally not disbursed through a centralized 
organizational payee, creating great potential for financial compliance violations and 
loss of research revenue. There may also be incomplete knowledge of research 
trials and activities occurring outside of the main hospital site (e.g., private practices, 
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affiliate sites, community outreach sites) which puts the hospital at risk for 
compliance violations.  
 
Ongoing Challenges 
Physician Participation in Research: Sixty percent of physicians surveyed by 
CenterWatch in 2006 said that they have referred patients to clinical trials. Those 
that had not referred patients into trials, explain that their number one hindrance to 
participation was the lack of information available about the treatments. 7% of these 
physicians said they feared losing the patient.” (Clinical Trial Facts and Figures) 
In the community hospital setting, physicians involved in research tend to 
exist in “pockets” without the advantage of institution-wide referrals as is common 
practice in most academic research settings.  This is generally due to the 
organization of the physicians and lack of structure to support research activities.  
Competing trials are often opened under the assumption that similar practices do not 
share patients.  In a climate of economic uncertainty, individual practices are 
unwilling to refer or “lose” patients to the practices of hospital colleagues.   
Patient referrals for research opportunities often mean the loss of income 
from standard of care procedures that would normally be performed in the referring 
physician‟s practice.  The fear of potential loss of income or patients to a competing 
physician‟s practice is not conducive to research collaboration.  In academia, 
physicians are contractually bound and incentivized to participate collaboratively in 
research endeavors.  
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“Even though most people do not rely on their physicians for information, 78% 
of the public say the physician is their most trusted source of information.”  (Clinical 
Trial Facts and Figures)  Increased knowledge of shared opportunities in the 
community hospital will provide opportunities for increased enrollments and 
institutional collaborations. Encouraging research collaborations through sub-
investigator partnerships, sharing of research trial information and educating patients 
about research options will stimulate collective interest in research growth.  
 
Ethical Challenges in Community Engagement 
People from various cultural or ethnic backgrounds hold different values and 
beliefs that may be different than principles of Western medicine. (National Cancer 
Institute, 2002)   In building the community hospital research program in Dearborn, 
Michigan, we are challenged to develop inclusive research practices.  We must be 
sensitive to the values and beliefs of the largely Muslim population in the 
surrounding community where chronic and mental illnesses are often viewed as a 
source of shame.  “Illnesses are generally hidden from disclosure for fear that 
people will view the condition as a sign of hereditary defect or as an indication that 
the family has earned the wrath of Divine Will, which might affect the social standing 
and marriageability of all associated family members. This has important bearing on 
the level of disclosure an outside surveyor, including a physician, will be able to 
uncover in a health interview. The sick individual would often prefer to hide than to 
seek care and face open disclosure of the „defect‟.”   (Hammad, 1999) 
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Approval of the Imam of a potential research subject‟s Mosque is a 
requirement prior to consenting to participate on a research trial.  Without the 
approval of the Imam, especially among the elder Muslim population, participation 
on the trial is not possible.  Expectations for modesty and appropriateness of 
conversational topics makes maintaining sensitivity to cultural issues a difficult 
barrier to fulfilling research requirements, such as informed consent, patient follow-
up and forms completion.  Some research trials, such as those exclusively exploring 
men‟s and women‟s health issues, face extreme design complications for inclusion 
as many trial activities are considered inappropriate and immoral.  
Much has been written about the effect of the Tuskgee Syphilis project on the 
participation of minorities in research. “The Tuskegee Syphilis Study remains one of 
the most outrageous examples of disregard of basic ethical principles of conduct 
(not to mention violation of standards for ethical research).” (Jones, 1981) 
As a result of this breach of research ethics, the trust level of minority 
populations is still in recovery.  “A survey conducted on 717 US adults in 2007 found 
high levels of public distrust in clinical research staff. The break down showed that 
this level of distrust was significantly higher in minority adults, as 73% said they were 
'very likely' or 'likely' to be treated as guinea pigs without their consent, whereas 
49% of whites responded this way.”  (Braunstein et.al., 2008) 
To ease distrust, community hospitals may increase participation in research by 
maintaining a presence in the community, providing research education to patients and 
staff, and developing the research infrastructure required to facilitate participation of all 
who choose investigational therapies as their treatment plan.  Providing access to 
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research therapies in addition to standards of healthcare, regardless of gender and 
ethnicity, fully complies with the intent of the regulations for inclusion of women and 
minorities in research.   
 
Healthcare Reform:  Impact on Clinical Research 
 The Patient Protection and Affordable Care Act (PPACA) was signed into law on 
March 23, 2010.  The main impact points of the PPACA on clinical research will be in 
the following areas. (Murtha, Forte, & Eskew, 2010): 
 Comparative effectiveness research through the establishment of Patient-
Centered Outcomes Research Institute will expand the scope of clinical research 
to include a value-based healthcare component through comparison of different 
therapies against one another. 
 Ensuring coverage for clinical trial participants.  Any group health plan will be 
prohibited from denying, limiting or imposing additional conditions on coverage 
for an individual participating in a clinical trial.  The same definition of Routine 
Care Costs as appears in the CMS Clinical Trials Policy is used in this legislation. 
 The qualifying therapeutic discovery project credit may promote more investment 
in research. 
 The Health Care Fraud and Abuse Control Fund will increase compliance 
enforcement efforts for the entire research community. 
 
Presuming that enrollment challenges escalate when potential research 
participants are denied coverage for the standard of care elements involved in some 
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research trials, the prohibition of insurance denial would provide incentive for those who 
might not otherwise agree to participate.  At the community hospital level, preparing for 
the changes by developing an appropriate research base solid in infrastructure and 
experience, to provide broad spectrum options for patients in all areas of intake will help 
to sustain the research program as well as the hospital long term.  Community hospital 
staff lacks the long term experience range of an academic site.  Strategic review of 
research trials and early acceptance of those trials contributing to the systematic 
development of research skills will ensure preparedness for state-of-the-art trials as 
training and education milestones are successfully attained.  
One recent study of 494 hospitals has shown that institutions that participate in 
clinical trials report lower mortality (deaths) from heart attacks, leading researchers to 
conclude that patients treated at hospitals that participate in clinical trials receive better 
quality of care and achieve better health outcomes than those treated at non- 
participating organizations. (Clinical Trial Facts and Figures) 
The deliberate nature of research allows for intensified scrutiny of all clinical and 
administrative activities over the course of a trial.  The increased level of consciousness 
becomes standard of practice over time for those who participate as investigators, 
research nurses, study coordinators or administrative research staff.  As quality 
outcomes become more prevalent in clinical practice, the implementation of a solid 
research infrastructure (Figure 2) will ensure a smooth transition into the new age of 
healthcare reform.  Collaborations in all areas of clinical practice will support increased 
quality of care and provide patients with cutting edge therapies that will improve 
healthcare outcomes.  
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Figure 2:  Sample Research Infrastructure 
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Conclusions 
The many challenges of implementing a sustainable clinical research 
infrastructure in a community hospital require a strategic analysis of existing hospital 
systems. This project must be a formal undertaking which is documented at each step 
to ensure full compliance with applicable regulations. 
Beginning with organizational leadership support is key; it is imperative to 
creating a sustained effort.  Organizational politics can be difficult to navigate without 
strong, supportive ethical leadership who will provide backing when new research 
initiatives are challenged or refused.  This is especially imperative when there has been 
no research leadership or oversight previously at the hospital.  Edgar Schein, Professor 
MIT Sloan School of Management, wrote, “We tend to think we can separate strategy 
from culture, but we fail to notice that in most organizations strategic thinking is deeply 
colored by tacit assumptions about who they are and what their mission is” (Schein, 
2004) Without program support at the Administrative and Executive levels of leadership, 
the culture of the organization will not be changed. 
At the systems level, the formation of a working group (or groups) to continually 
address ongoing research operational issues is a critical step to ensuring thorough 
education and training of hospital operations personnel regarding research regulations.  
Building a strong research program should be an effort inclusive of all stakeholders.  
This will alleviate the level of push-back that can occur in the community hospital. 
Community hospitals often do not view research as an essential service.  
Exposure to research systems processes in this setting is the exception rather than the 
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rule. Bringing supporting departments together to work through research challenges 
encourages investment in all infrastructure levels.  Working groups enable departmental 
leaders to develop processes to facilitate research that is sensible for their respective 
departments. Implementation of system-wide policies, written collaboratively with 
hospital infrastructure support units, will educate and standardize procedures.  
Integration of some type of clinical trials management system or software is also an 
imperative to achieving improvements in communication, centralized financial tracking 
and regulatory compliance across all participating hospital sites. Without the centralized 
ability to communicate in real time regarding trial activities, compliance and accuracy in 
recordkeeping will be compromised. 
If there is to be sustainability, there must also be improvement in the service we 
provide to the communities in which we practice.  The development of programs 
designed for accessibility and education of community partners, organizations and 
individuals will encourage those who have not considered participating in clinical 
research to explore options for future participation.  Becoming involved as a research 
organization with community groups will allow deeper exploration of cultural barriers to 
research and may provide avenues to integrate updates into existing systems to 
improve minority participation.  A more consistent presence in developing community 
partnerships for research education will improve public perception and research 
accessibility, ultimately leading to greater community support and increased 
participation and improved health status. 
Building successful and sustainable clinical research infrastructure in a 
community hospital without developing the organizational research culture and 
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addressing the needs of community will not support success. Formal planning, strategic 
systems design, consistency of compliance efforts and message, and dedication to the 
end result will improve possibilities for sustainability over time. Designing a compliant, 
robust research program with an appropriately directed portfolio of options for patients 
will build credibility and bring the best research and researchers to the hospital.  Goal 
attainment is linked to strategic organizational support, financial viability, regulatory 
compliance, physician participation, visibility, appropriate research portfolio, and 
inclusion of the community served by the hospital.    
 
 C l i n i c a l  R e s e a r c h  i n  C o m m u n i t y  H o s p i t a l s   
 
22 | P a g e  
 
References 
American Public Health Association. (2004). Race & Research: Perspectives on 
Minority Participation in Health Studies. (D. a. Bettina M. Beech, Ed.) Washington, DC: 
American Public Health Association. 
 
Baquet, C. R., Commiskey, P. M., Mullins, D. P., & Mishra, S. I. (2006, 12 13). 
Recruitment and participation in clinical trials: Socio-demographic, rural/urban, and 
health care access predictors. Cancer Detection and Prevention 30 , 24-33. 
 
Braunstein, J. B., Sherber, N. S., Schulman, S. P., Ding, E. L., & Powe, N. R. (2008). 
Race, Medical Researcher Distrust, Perceived Harm, and Willingness to Participate in 
Cardiovascular Prevention Trials. Medicine , Volume 87 - Issue 1 - pp 1-9. 
 
Clinical Trial Facts and Figures. (n.d.). Retrieved November 01, 2010, from The Center 
for Information & Study on Clinical Research Participation: http://www.cisrp.org 
 
Democratic Policy Committee. (2010). Affordable Care Act. Retrieved 11 03, 2010, from 
http://dpc.senate.gov/reform 
 
Epstein, S. (2007). Inclusion: The Politics of Difference in Medical Research. Chicago 
and London: The University of Chicago Press. 
 
Hammad, A. P. (1999, April). Guide to Arab Culture: Health Care Delivery to the Arab 
American Community. Retrieved November 3, 2010, from Arab Community Center for 
Economic and Social Services: http://www.accesscommunity.org 
 
Jones, J. (1981). Bad blood: The Tuskegee syphilis experiment: A tragedy of race and 
medicine. NY: The Free Press. Murtha, L., Forte, D., & Eskew, K. (2010, May 21). 
Retrieved November 01, 2010, from Mondaq: www.mondaq.com 
 
Mussey, S. M. (2010, 04 22). Patient Protection and Affordable Care Act. Retrieved 11 
03, 2010, from Department of Health and Human Services: http://www.dhhs.gov 
 
National Cancer Institute. (2002, 09 26). Cancer Clinical Trials: The In-Depth Program. 
Retrieved 11 03, 2010, from National Cancer Institute: 
http://cancer.gov/clinicaltrials/education/in-depth-program 
 
Nelson, R. (2009, 02 10). Retrieved 10 30, 2010, from Medscape Medical News: 
www.medscape.com 
 
Schein, E. H. (2004). Organizational Culture and Leadership, 3rd ed. San Francisco,  
CA: Jossey-Bass. 
 
Trimble, J. E., & Fisher, C. B. (2006). The Handbook of Ethical Research with 
Ethnocultural Populations and Communities. Thousand Oaks, CA: Sage Publications, 
Inc. 
 C l i n i c a l  R e s e a r c h  i n  C o m m u n i t y  H o s p i t a l s   
 
23 | P a g e  
 
 
Wendler, D., Kington, R., Madans, J., Van Wye, G., Christ-Schmidt, H., & al, e. (2005). 
Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? PLOS 
Medicine , Volume 3, Issue 2, e19. 
 
 
 
